Ex-Beckman Coulter executive to lead Seegene's US office
Richard S. Creager, CEO of Seegene's United States subsidiary / Courtesy of SeegeneBy Baek Byung-yeulRichard S. Creager, a former chief science officer of U.S.-based medical diagnostics company Beckman Coulter, was appointed as CEO of Korean diagnostics company Seegene's U.S. subsidiary.Seegene, the country's leading diagnostics company, said Wednesday that it appointed Creager to lead its U.S. subsidiary as part of its plan to strengthen business there.Creager holds a Ph.D. in microbiology from the School of Medicine at the University of Pittsburgh. As former chief science officer and executive officer for Beckman Coulter, he has diverse experience in developing new products, technologies and business models for the diagnostic, laboratory services and business-to-business sectorsSeegene gained global attention as an early assay provider when COVID-19 infections were spreading at an increasingly rapid pace in early 2020. However, the company said its presence has been relatively limited in the U.S., the world's largest molecular diagnostics market.“With Dr. Creager's expertise
